One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

A new study in cats with a fatal coronavirus infection suggests stem cell therapy could help tackle the immune damage behind ...

During a recent interview on Bobby Bones’ “BobbyCast” podcast, country singer Trisha Yearwood revealed which treatment helped ...

Infants, toddlers and preschoolers exhibit symptoms of long COVID, but the symptoms can be different and more difficult to ...

With a simple skin biopsy, researchers can learn about neurological conditions that may be associated with long COVID.

Since there are still no long-COVID treatments approved by the Food and Drug Administration, anything a physician prescribes is classified as either experimental — for unproven treatments — or ...

Despite long Covid's vast reach, the federal government's investment in researching the disease — to the tune of $1.15 billion to date — has so far failed to bring any new treatments to market.

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.